Asr Vermogensbeheer N.V. Alnylam Pharmaceuticals, Inc. Call Options Transaction History
Asr Vermogensbeheer N.V.
- $8.24 Trillion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ALNY
# of Institutions
840Shares Held
118MCall Options Held
608KPut Options Held
678K-
Capital World Investors Los Angeles, CA16.8MShares$7.42 Billion0.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.6MShares$5.99 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$4.22 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.19MShares$3.18 Billion0.49% of portfolio
-
Jpmorgan Chase & CO New York, NY4.54MShares$2.01 Billion0.14% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $54.3B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...